Article metrics

Original research
Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC)

 

Online download statistics by month:

Online download statistics by month: March 2021 to April 2021

AbstractFullPdf
Mar 2021268268214
Apr 2021529529199
Total797797413